1. Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russia 2. Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russia; Institute of Experimental Medicine, Saint-Petersburg, Russia 3. Institute of Experimental Medicine, Saint-Petersburg, Russia; Saint-Petersburg State University, Saint-Petersburg, Russia 4. Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russia; Pirogov Russian National Research Medical University, Moscow, Russia
This study was carried out to compare the enzymatic and bactericidal activity of mature, dimeric myeloperoxidase (MPO) and its monomeric form. Dimeric MPO was isolated from HL-60 cells. Hemi-MPO obtained from dimeric MPO by reductive cleavage of a disulfide bond between protomeric subunits was used as the monomeric form. Both peroxidase and halogenating (chlorinating) activities of MPO were assayed, each of them by two methods. Bactericidal activity of the MPO/Н2О2/Cl- system was tested using the Escherichia coli laboratory strain DH5a. No difference in the enzymatic and bactericidal activity between dimeric MPO and hemi-MPO was found. Both forms of the enzyme also did not differ in the resistance to HOCl, the main product of MPO. HOCl caused a dose-dependent decrease in peroxidase and chlorinating activity, and the pattern of this decrease was identical for dimeric MPO and hemi-MPO. At equal heme concentration, a somewhat higher bactericidal effect was observed for the hemi-MPO/Н2О2/Cl- system compared with the dimeric MPO/Н2О2/Cl- system. However, this is most likely not related to some specific property of hemi-MPO and can be accounted for by the higher probability of contacting between bacterial surface and hemi-MPO molecules due to their two-fold greater number relative to that of dimeric MPO molecules at the same heme concentration. By using Western-blotting with antibodies to MPO, we showed, for the first time, that the dimeric molecule of MPO could be cleaved into two monomeric subunits by HOCl, most probably due to oxidation of the disulfide bond between these subunits. This finding suggests that appearance in blood of MPO corresponding in mass to its monomer may result from the damage of dimeric MPO by reactive halogen species, especially upon their overproduction underlying oxidative/halogenative stress in inflammatory diseases.
Vakhrusheva T.V., Sokolov A.V., Kostevich V.A., Vasilyev V.B., Panasenko O.M. (2018) Enzymatic and bactericidal activity of monomeric and dimeric forms of myeloperoxidase. Biomeditsinskaya Khimiya, 64(2), 175-182.
Vakhrusheva T.V. et al. Enzymatic and bactericidal activity of monomeric and dimeric forms of myeloperoxidase // Biomeditsinskaya Khimiya. - 2018. - V. 64. -N 2. - P. 175-182.
Vakhrusheva T.V. et al., "Enzymatic and bactericidal activity of monomeric and dimeric forms of myeloperoxidase." Biomeditsinskaya Khimiya 64.2 (2018): 175-182.
Vakhrusheva, T. V., Sokolov, A. V., Kostevich, V. A., Vasilyev, V. B., Panasenko, O. M. (2018). Enzymatic and bactericidal activity of monomeric and dimeric forms of myeloperoxidase. Biomeditsinskaya Khimiya, 64(2), 175-182.
Johnson K.R., Nauseef W.M., Care A., Wheelock M.J., Shane S., Hudson S., Koeffler H.P., Selsted M., Miller C., Rovera G. (1987) Nucleic Acids Res., 15(5), 2013-2028. CrossRef Scholar google search
Gullberg U., Bengtsson N., Bulow E., Garwicz D., Lindmark A., Olsson I. (1999) J. Immunol. Methods, 232(1-2), 201-210. CrossRef Scholar google search
